|
1
|
Dressler GR: The cellular basis of kidney
development. Annu Rev Cell Dev Biol. 22:509–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Little MH and McMahon AP: Mammalian kidney
development: Principles, progress, and projections. Cold Spring
Harb Perspect Biol. 4(pii): a0083002012.PubMed/NCBI
|
|
3
|
Lindström NO, Lawrence ML, Burn SF,
Johansson JA, Bakker ER, Ridgway RA, Chang CH, Karolak MJ, Oxburgh
L, Headon DJ, et al: Integrated β-catenin, BMP, PTEN, and Notch
signalling patterns the nephron. Elife. 3:e040002015.PubMed/NCBI
|
|
4
|
Motamedi FJ, Badro DA, Clarkson M, Lecca
MR, Bradford ST, Buske FA, Saar K, Hübner N, Brändli AW and Schedl
A: WT1 controls antagonistic FGF and BMP-pSMAD pathways in early
renal progenitors. Nat Commun. 5:44442014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Armstrong JF, Pritchard-Jones K, Bickmore
WA, Hastie ND and Bard JB: The expression of the Wilms' tumour
gene, WT1, in the developing mammalian embryo. Mech Dev. 40:85–97.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pritchard-Jones K, Fleming S, Davidson D,
Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J,
Housman D, et al: The candidate Wilms' tumour gene is involved in
genitourinary development. Nature. 346:194–197. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berry RL, Ozdemir DD, Aronow B, Lindström
NO, Dudnakova T, Thornburn A, Perry P, Baldock R, Armit C, Joshi A,
et al: Deducing the stage of origin of Wilms' tumours from a
developmental series of Wt1-mutant mice. Dis Model Mech. 8:903–917.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kirschner KM, Braun JF, Jacobi CL,
Rudigier LJ, Persson AB and Scholz H: Amine oxidase
copper-containing 1 (AOC1) is a downstream target gene of the Wilms
tumor protein, WT1, during kidney development. J Biol Chem.
289:24452–24462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Donovan MJ, Natoli TA, Sainio K, Amstutz
A, Jaenisch R, Sariola H and Kreidberg JA: Initial differentiation
of the metanephric mesenchyme is independent of WT1 and the
ureteric bud. Dev Genet. 24:252–262. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cannell IG, Kong YW and Bushell M: How do
microRNAs regulate gene expression? Biochem Soc Trans.
36:1224–1231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z: miRNA in the regulation of ion
channel/transporter expression. Compr Physiol. 3:599–653.
2013.PubMed/NCBI
|
|
12
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ho J and Kreidberg JA: The long and short
of microRNAs in the kidney. J Am Soc Nephrol. 23:400–404. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lyu Z, Mao Z, Wang H, Fang Y, Chen T, Wan
Q, Wang M, Wang N, Xiao J, Wei H, et al: MiR-181b targets Six2 and
inhibits the proliferation of metanephric mesenchymal cells in
vitro. Biochem Biophys Res Commun. 440:495–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv X, Mao Z, Lyu Z, Zhang P, Zhan A, Wang
J, Yang H, Li M, Wang H, Wan Q, et al: miR181c promotes apoptosis
and suppresses proliferation of metanephric mesenchyme cells by
targeting Six2 in vitro. Cell Biochem Funct. 32:571–579. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang X, Wang X, Nie F, Liu T, Yu X, Wang
H, Li Q, Peng R, Mao Z, Zhou Q and Li G: miR-135 family members
mediate podocyte injury through the activation of Wnt/β-catenin
signaling. Int J Mol Med. 36:669–677. 2015.PubMed/NCBI
|
|
17
|
Sun H, Li QW, Lv XY, Ai JZ, Yang QT, Duan
JJ, Bian GH, Xiao Y, Wang YD, Zhang Z, et al: MicroRNA-17
post-transcriptionally regulates polycystic kidney disease-2 gene
and promotes cell proliferation. Mol Biol Rep. 37:2951–2958. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ranganathan P, Jayakumar C, Tang Y, Park
KM, Teoh JP, Su H, Li J, Kim IM and Ramesh G: MicroRNA-150 deletion
in mice protects kidney from myocardial infarction-induced acute
kidney injury. Am J Physiol Renal Physiol. 309:F551–F558. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hastie ND: The genetics of Wilms' tumor -
a case of disrupted development. Annu Rev Genet. 28:523–558. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong L, Pietsch S and Englert C: Towards
an understanding of kidney diseases associated with WT1 mutations.
Kidney Int. 88:684–690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eckardt KU, Coresh J, Devuyst O, Johnson
RJ, Köttgen A, Levey AS and Levin A: Evolving importance of kidney
disease: From subspecialty to global health burden. Lancet.
382:158–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
